Abstract
Myricetin is one of the principal phytochemicals in onions, berries and red wine. Previous studies showed that myricetin exhibits potent anticancer and chemopreventive effects. The present study examined the effect of myricetin on ultraviolet (UV) B-induced angiogenesis in an SKH-1 hairless mouse skin tumorigenesis model. Topical treatment with myricetin inhibited repetitive UVB-induced neovascularization in SKH-1 hairless mouse skin. The induction of vascular endothelial growth factor, matrix metalloproteinase (MMP)-9 and MMP-13 expression by chronic UVB irradiation was significantly suppressed by myricetin treatment. Immunohistochemical and western blot analyses revealed that myricetin inhibited UVB-induced hypoxia inducible factor-1α expression in mouse skin. Western blot analysis and kinase assay data revealed that myricetin suppressed UVB-induced phosphatidylinositol-3 (PI-3) kinase activity and subsequently attenuated the UVB-induced phosphorylation of Akt/p70S6K in mouse skin lysates. A pull-down assay revealed the direct binding of PI-3 kinase and myricetin in mouse skin lysates. Our results indicate that myricetin suppresses UVB-induced angiogenesis by regulating PI-3 kinase activity in vivo in mouse skin.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 911-917 |
| Number of pages | 7 |
| Journal | Carcinogenesis |
| Volume | 31 |
| Issue number | 5 |
| DOIs | |
| State | Published - Dec 11 2009 |
Bibliographical note
Funding Information:World Class University program (R31-2008-00-10056-0) through the Korea Science and Engineering Foundation, the Ministry of Education, Science and Technology; BioGreen 21 Program (20070301-034-042 and 027), Rural Development Administration; The Hormel Foundation and National Institutes of Health (CA077646, CA111536, CA120388, ES016548).
